Clinical Trial Update: Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial from the University of Michigan evaluates talazoparib in combination with belinostat in metastatic breast cancer, metastatic castration-resistan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• Belinostat (belinostat)
• Talazoparib (talazoparib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1 | Status: COMPLETED